Class Action

Similac, Alimentum, and EleCare

Class Action

Similac, Alimentum, and EleCare


Case Name (Date)

Ephraim et al. v. Abbott Laboratories, Inc.
22-cv-20516, S.D. Fla.
(Feb. 2022)

Harkless et al. v. Abbott Laboratories Inc.
22-cv-1097, N.D. Ill.
(Feb. 2022)

Steele et al. v. Abbott Laboratories Inc.
22-cv-571, D.S.C.
(Feb. 2022)


Product/Service

Similac, Alimentum, and EleCare powdered infant formulas


Allegations

Misleadingly marketing formulas as safe when they cause serious health problems, including bacterial infections and gastrointestinal illnesses


Status

Pending



Class-Action Tracker

Glucerna

Class Action

Glucerna

Allegations: Falsely marketing that products are “specifically designed for people with diabetes” and “help manage blood sugar” when they contain ingredients that negatively affect blood sugar levels and gut health

PediaSure Grow & Gain

Class Action

PediaSure Grow & Gain

Allegations: Falsely marketing that products are “clinically proven to help kids grow” when scientific evidence shows such claims are not true


The Latest

Filters